Medicared For All Logo

Radha Rao in Cherokee, Iowa

Home Iowa Cherokee

Radha Rao has Hematology/oncology as her primary medical specialty. Their primary office is: 300 Sioux Valley Dr in Cherokee, Iowa. There are 2 additional office locations for Radha Rao that can be viewed towards the end of their profile.

They're a part of the: Siouxland Regional Cancer Center medical group which has around 13 members. You can call their office at 712-225-5101 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, her university is not listed and graduated in 1977 (around 47 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.


Radha M Rao Office Phone and Directions

Radha Rao
Siouxland Regional Cancer Center
300 Sioux Valley Dr
Cherokee, Iowa 51012
712-225-5101


Patient Ratings
Please rate your experience with Radha Rao below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 712-225-5101


Enter a starting address:


Healthcare Info for Radha Rao

Medical School: Sorry, her university is not listed
Graduation Year: 1977
The Primary Medical Specialty for Radha Rao is listed as: Hematology/oncology
Approximate Years of Experience: 47
PAC (PECOS ID)#: 8022104686
NPI #: 1699746016
NPI Created On: 02/01/2006
NPI Last Updated Listed as: 02/05/2015
Primary Taxonomy Code: 207RH0003X
License Number:
29208
Listed Gender: Female

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Sanford Health Plan
  • Avera Health Plans, Inc.
  • Medica Insurance Company
  • Humana
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.


Services and Procedures include:

  1. Insertion of needle into vein for collection of blood sample
  2. Blood test, comprehensive group of blood chemicals
  3. Carcinoembryonic antigen (cea) protein level
  4. Ferritin (blood protein) level
  5. Iron level
  6. Iron binding capacity
  7. Lactate dehydrogenase (enzyme) level
  8. Blood test, thyroid stimulating hormone (tsh)
  9. Complete blood cell count (red cells, white blood cell, platelets), automated test
  10. Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
  11. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
  12. Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
  13. Infusion of chemotherapy into a vein up to 1 hour
  14. Infusion of chemotherapy into a vein
  15. Infusion of different chemotherapy drug or substance into a vein up to 1 hour
  16. Established patient office or other outpatient visit, typically 15 minutes
  17. Established patient office or other outpatient, visit typically 25 minutes
  18. Established patient office or other outpatient, visit typically 40 minutes
  19. Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l
  20. Injection, leucovorin calcium, per 50 mg

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788576645

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09


Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 795776315

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: VENCLEXTA

Open Associated Drug #1: 0074-0576-22


Payments Total: $100

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 795776319

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: VENCLEXTA

Open Associated Drug #1: 0074-0576-22


Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802933411

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: ONCOLOGY

Name of Drug #1: BLENREP

Open Associated Drug #1: 0173-0896-01


Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832157231

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: TUKYSA

Open Associated Drug #1: 51144-001-60


Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832157247

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: PADCEV

Open Associated Drug #1: 51144-030-01


Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832157343

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: TIVDAK

Open Associated Drug #1: 51144-003-01


Payments Total: $19

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783693239

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Hematology

Name of Drug #1: REBLOZYL

Open Associated Drug #1: 59572-711-01


Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 826538097

Being Disputed:: No

Product Related: No


Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Context of payment:: ;G2781044;EPRINTS;10717226

Record ID:: 845878187

Being Disputed:: No

Product Related: Yes


Additional Office Locations

1. Siouxland Regional Cancer Center
230 Nebraska St
Sioux City, IA 51101
June E Nylen Cancer Center
Group Members: 13

Phone: 712-225-5101

Enter a starting address:


2. Siouxland Regional Cancer Center
1000 Lincoln Cir Se
Orange City, IA 51041
Group Members: 13

Phone: 712-225-5101

Enter a starting address:


Providers in Siouxland Regional Cancer Center

1.Nibash Budhathoki

1600 Diamond St
Onawa Ia 51040-1548
Siouxland Regional Cancer Center
Hematology/oncology

2.Nibash Budhathoki

801 5th St
Sioux City Ia 51101-1326
Siouxland Regional Cancer Center
Hematology/oncology

3.Nibash Budhathoki

230 Nebraska St
Sioux City Ia 51101-1733
Siouxland Regional Cancer Center
Hematology/oncology

4.Nibash Budhathoki

2720 Stone Park Blvd
Sioux City Ia 51104-3734
Siouxland Regional Cancer Center
Hematology/oncology

5.Nibash Budhathoki

1525 W 5th St
Storm Lake Ia 50588-3027
Siouxland Regional Cancer Center
Hematology/oncology

6.Lisa Chaiken Md

230 Nebraska St
Sioux City Ia 51101-1733
Siouxland Regional Cancer Center
Radiation Oncology

View all 13 members of Siouxland Regional Cancer Center medical group